Showing 301 results
  • Fiona H. Marshall, Ph.D., President, Biomedical Research
    Image
    lock
    Leadership / Image
    Fiona H. Marshall, Ph.D.

    President, Biomedical Research

  • Vasant (Vas) Narasimhan, M.D., Chief Executive Officer (CEO)
    Image
    lock
    Leadership / Image
    Vasant (Vas) Narasimhan, M.D.

    Chief Executive Officer since 2018

  • Vasant (Vas) Narasimhan, M.D., Chief Executive Officer (CEO)
    Image
    lock
    Leadership / Image
    Vasant (Vas) Narasimhan, M.D.

    Chief Executive Officer since 2018

  • Video
    lock
    Video
    Security of supply

    We must work together to protect the security of medicine supply - learn more about the ways we can ensure this is a reality for all Europeans.

  • Video
    lock
    Video
    Orphan Medicinal Products & Pediatrics

    When it comes to orphan and paediatric medicines, a collaborative approach is essential.

  • Video
    lock
    Video
    Regulatory (EMA)

    A smart and future-proof framework can foster innovation in the EU while ensuring faster and widespread access to medicines.

  • Video
    lock
    Video
    Intellectual property, including regulatory data protection (RDP)

    The EU has an opportunity to ensure that we create a predictable and robust framework that leads to more investments and treatments for patients.

  • Video
    lock
    Novartis Access / Video
    Access to medicines in EU Member States

    While everyone agrees that better access to medicines is important, the challenge with using the regulatory framework to achieve this objective is that it's not the right tool for the task.

  • View of the Novartis logo through the colorful façade of Forum 3, Novartis Campus Basel (vertical)
    Image
    lock
    Image
    Novartis logo through the colorful facade of Forum 3, Novartis Campus Basel (vertical)

    View of the Novartis logo through the colorful facade of Forum 3, Novartis Campus Basel (vertical)

  • View of the Novartis logo on the Banting 1 building, Novartis Campus Basel (horizontal)
    Image
    lock
    Image
    Novartis logo on the Banting 1 building, Novartis Campus Basel (horizontal)

    View of the Novartis logo on the Banting 1 building, Novartis Campus Basel (horizontal)

  • Close up of the Novartis logo on the Banting 1 building, Novartis Campus Basel (vertical)
    Image
    lock
    Image
    Novartis logo on the Banting 1 building, Novartis Campus Basel (vertical)

    Close up of the Novartis logo on the Banting 1 building, Novartis Campus Basel (vertical)

  • View of the Novartis logo on the Banting 1 building, Novartis Campus Basel (vertical)
    Image
    lock
    Image
    Novartis logo on the Banting 1 building, Novartis Campus Basel (vertical)

    View of the Novartis logo on the Banting 1 building, Novartis Campus Basel (vertical)